Cancer treatment co UroGen invests $7m in Israel’s IntraGel...
UroGen has invested $7 million in Israel’s IntraGel, a company developing a gel-based cancer treatment.
The gel’s key features include injectability and biodegradability inside the body.
UroGen has invested $7 million in Israel’s IntraGel, a company developing a gel-based cancer treatment.
The gel’s key features include injectability and biodegradability inside the body.